{"denomUnitsSelected":"Participants","description":"To estimate median OS in patients with intermediate-risk HNSCC treated with adjuvant durvalumab with radiotherapy.-To correlate PD-L1 expression with disease free survival","reportingStatus":"NOT_POSTED","timeFrame":"5 years","title":"Overall Survial in Patients With Intermediate-risk HNSCC Treated With Adjuvant Durvalumab With Radiotherapy PD-L1 Expression With Disease Free Survival","type":"SECONDARY"}